Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

2.

"Neurophobia": More Nurture than Nature?

Conway S, Tubridy N.

Ir Med J. 2018 Mar 14;111(3):710.

PMID:
30376228
3.

IRAK1 Limits TLR3/4- and IFNAR-Driven IL-27 Production through a STAT1-Dependent Mechanism.

Bruni D, Dignam A, Dunne S, Wall-Coughlan D, McCrudden A, O'Connell K, Lyons C, McGuigan C, Tubridy N, Butler MP.

J Immunol. 2018 Oct 1;201(7):2070-2081. doi: 10.4049/jimmunol.1701373. Epub 2018 Aug 24.

4.

Encephalitis with mGluR5 antibodies: Symptoms and antibody effects.

Spatola M, Sabater L, Planagumà J, Martínez-Hernandez E, Armangué T, Prüss H, Iizuka T, Caparó Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, Dalmau J.

Neurology. 2018 May 29;90(22):e1964-e1972. doi: 10.1212/WNL.0000000000005614. Epub 2018 Apr 27.

5.

New versus old: Implications of evolving diagnostic criteria for relapsing-remitting multiple sclerosis.

McNicholas N, Lockhart A, Yap SM, O'Connell K, Tubridy N, Hutchinson M, McGuigan C.

Mult Scler. 2019 May;25(6):867-870. doi: 10.1177/1352458518770088. Epub 2018 Apr 12.

PMID:
29648501
6.

Machine Learning EEG to Predict Cognitive Functioning and Processing Speed Over a 2-Year Period in Multiple Sclerosis Patients and Controls.

Kiiski H, Jollans L, Donnchadha SÓ, Nolan H, Lonergan R, Kelly S, O'Brien MC, Kinsella K, Bramham J, Burke T, Hutchinson M, Tubridy N, Reilly RB, Whelan R.

Brain Topogr. 2018 May;31(3):346-363. doi: 10.1007/s10548-018-0620-4. Epub 2018 Jan 29.

PMID:
29380079
7.

Transient global amnesia: clinical and imaging features.

Kavanagh RG, O'Brien A, Tubridy N, McNeill G, Killeen RP.

QJM. 2017 Aug 28. doi: 10.1093/qjmed/hcx168. [Epub ahead of print] No abstract available.

PMID:
29024985
8.

Effects of vitamin D3 in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trial.

O'Connell K, Sulaimani J, Basdeo SA, Kinsella K, Jordan S, Kenny O, Kelly SB, Murphy D, Heffernan E, Killeen RP, Mulready K, MacMahon M, Brady JJ, McKenna C, Muldowney C, Cassidy L, Walsh C, O'Rourke K, Tubridy N, McGuigan C, Fletcher JM, Hutchinson M.

Mult Scler J Exp Transl Clin. 2017 Sep 21;3(3):2055217317727296. doi: 10.1177/2055217317727296. eCollection 2017 Jul-Sep.

9.

Analysing the effect of multiple sclerosis on vitamin D related biochemical markers of bone remodelling.

McKenna MJ, Murray B, Lonergan R, Segurado R, Tubridy N, Kilbane MT.

J Steroid Biochem Mol Biol. 2018 Mar;177:91-95. doi: 10.1016/j.jsbmb.2017.09.002. Epub 2017 Sep 6.

PMID:
28887146
10.
11.

Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.

O'Connell K, Tubridy N, Hutchinson M, McGuigan C.

Mult Scler Relat Disord. 2017 Apr;13:75-80. doi: 10.1016/j.msard.2017.02.010. Epub 2017 Feb 14.

PMID:
28427707
12.

Neurosarcoidosis: clinical presentations and changing treatment patterns in an Irish Caucasian population.

O'Connell K, Williams L, Jones J, McCabe DJH, Murphy D, Killeen R, Tubridy N, O'Riordan S, McGuigan C.

Ir J Med Sci. 2017 Aug;186(3):759-766. doi: 10.1007/s11845-016-1539-y. Epub 2017 Jan 18.

PMID:
28101825
13.

An Audit of the Effectiveness of Large Group Neurology Tutorials for Irish Undergraduate Medical Students.

Kearney H, Krakar A, Drazyk A, Maloney E, Callinan I, Tubridy N.

Ir Med J. 2016 Aug 8;109(7):438.

PMID:
27834089
14.

Myasthenia gravis: a population-based epidemiological study.

Rutledge S, Kenny O, O'Riordan S, McGuigan C, Tubridy N.

Ir Med J. 2016 Feb 19;109(2):355.

PMID:
27685688
15.

Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis.

Fogarty E, Schmitz S, Tubridy N, Walsh C, Barry M.

Mult Scler Relat Disord. 2016 Sep;9:23-30. doi: 10.1016/j.msard.2016.06.001. Epub 2016 Jun 8. Review.

PMID:
27645339
16.

Increased expression of Tbet in CD4(+) T cells from clinically isolated syndrome patients at high risk of conversion to clinically definite MS.

Basdeo SA, Kelly S, O'Connell K, Tubridy N, McGuigan C, Fletcher JM.

Springerplus. 2016 Jun 18;5(1):779. doi: 10.1186/s40064-016-2510-0. eCollection 2016.

17.

Visualisation of the medial longitudinal fasciculus using fibre tractography in multiple sclerosis patients with internuclear ophthalmoplegia.

McNulty JP, Lonergan R, Bannigan J, O'Laoide R, Rainford LA, Tubridy N.

Ir J Med Sci. 2016 May;185(2):393-402. doi: 10.1007/s11845-016-1405-y. Epub 2016 Jan 19.

PMID:
26787313
18.

Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.

Kiiski HS, Ní Riada S, Lalor EC, Gonçalves NR, Nolan H, Whelan R, Lonergan R, Kelly S, O'Brien MC, Kinsella K, Bramham J, Burke T, Ó Donnchadha S, Hutchinson M, Tubridy N, Reilly RB.

PLoS One. 2016 Jan 4;11(1):e0146084. doi: 10.1371/journal.pone.0146084. eCollection 2016.

19.

A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).

O'Connell K, Langdon D, Tubridy N, Hutchinson M, McGuigan C.

Mult Scler Relat Disord. 2015 Nov;4(6):521-5. doi: 10.1016/j.msard.2015.07.012. Epub 2015 Aug 7.

PMID:
26590658
20.

Anti-NMDA-receptor antibody-mediated cortical blindness: a case report.

Rutledge S, Chalissery A, O'Connor R, Mahon S, Connolly S, Farrell M, Crowley P, MacSweeney F, Tubridy N.

QJM. 2016 Feb;109(2):127-8. doi: 10.1093/qjmed/hcv151. Epub 2015 Aug 28. No abstract available.

PMID:
26319702
21.

Multifocal Motor Neuropathy Associated with Infliximab.

Rowan CR, Tubridy N, Cullen G.

J Crohns Colitis. 2015 Dec;9(12):1174-5. doi: 10.1093/ecco-jcc/jjv137. Epub 2015 Jul 29.

PMID:
26223843
22.

Posterior cortical and white matter changes on MRI in anti-AMPA receptor antibody encephalitis.

Elamin M, Lonergan R, Killeen RP, O'Riordan S, Tubridy N, McGuigan C.

Neurol Neuroimmunol Neuroinflamm. 2015 May 21;2(4):e118. doi: 10.1212/NXI.0000000000000118. eCollection 2015 Aug. No abstract available.

23.

Assessment and classification of early-stage multiple sclerosis with inertial sensors: comparison against clinical measures of disease state.

Greene BR, Rutledge S, McGurgan I, McGuigan C, OConnell K, Caulfield B, Tubridy N.

IEEE J Biomed Health Inform. 2015 Jul;19(4):1356-61. doi: 10.1109/JBHI.2015.2435057. Epub 2015 Jun 17.

PMID:
26087505
24.

Should we call the neurologist? The value and cost of a growing neurology consultation service.

Broderick N, Farrell C, Tubridy N.

Ir J Med Sci. 2016 Aug;185(3):611-6. doi: 10.1007/s11845-015-1317-2. Epub 2015 Jun 4.

PMID:
26037637
25.

Economic costs associated with an MS relapse.

O'Connell K, Kelly SB, Fogarty E, Duggan M, Buckley L, Hutchinson M, McGuigan C, Tubridy N.

Mult Scler Relat Disord. 2014 Nov;3(6):678-83. doi: 10.1016/j.msard.2014.09.002. Epub 2014 Sep 16.

PMID:
25891546
26.

Unmet needs of multiple sclerosis patients in the community.

Lonergan R, Kinsella K, Fitzpatrick P, Duggan M, Jordan S, Bradley D, Hutchinson M, Tubridy N.

Mult Scler Relat Disord. 2015 Mar;4(2):144-50. doi: 10.1016/j.msard.2015.01.003. Epub 2015 Feb 3.

PMID:
25787190
27.

Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test.

Greene BR, Healy M, Rutledge S, Caulfield B, Tubridy N.

Conf Proc IEEE Eng Med Biol Soc. 2014;2014:2977-80. doi: 10.1109/EMBC.2014.6944248.

PMID:
25570616
28.

Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.

Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, Correia de Sá J, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y.

J Neurol. 2015 Jan;262(1):248. doi: 10.1007/s00415-014-7565-7. No abstract available.

29.

Direct and indirect economic consequences of multiple sclerosis in Ireland.

Fogarty E, Walsh C, McGuigan C, Tubridy N, Barry M.

Appl Health Econ Health Policy. 2014 Dec;12(6):635-45. doi: 10.1007/s40258-014-0128-3.

PMID:
25227118
30.

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.

Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, de Sá JC, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y.

J Neurol. 2014 Nov;261(11):2101-11. doi: 10.1007/s00415-014-7446-0. Epub 2014 Aug 14. Erratum in: J Neurol. 2015 Jan;262(1):248.

31.

Paraneoplastic dentate ganglionopathy: clinical and neuroimmunologic studies.

O'Toole O, Murphy O, O'Dwyer J, Lonergan R, Keogh B, Tubridy N, Lynch T, Farrell M.

Clin Neuropathol. 2015 Jan-Feb;34(1):34-9. doi: 10.5414/NP300754.

PMID:
25074875
32.

Headaches, neurologists and the emergency department.

Gaughran CG, Tubridy N.

Ir Med J. 2014 Jun;107(6):168-71.

PMID:
24988831
33.

Diagnostic Efficacy of Conventional MRI Pulse Sequences in the Detection of Lesions Causing Internuclear Ophthalmoplegia in Multiple Sclerosis Patients.

McNulty JP, Lonergan R, Brennan PC, Evanoff MG, O'Laoide R, Ryan JT, Tubridy N.

Clin Neuroradiol. 2015 Sep;25(3):233-9. doi: 10.1007/s00062-014-0295-5. Epub 2014 Mar 6.

PMID:
24599322
34.

Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial.

O'Connell K, Kelly S, Kinsella K, Jordan S, Kenny O, Murphy D, Heffernan E, O'Laoide R, O'Shea D, McKenna C, Cassidy L, Fletcher J, Walsh C, Brady J, McGuigan C, Tubridy N, Hutchinson M.

Trials. 2013 Aug 27;14:272. doi: 10.1186/1745-6215-14-272.

35.

Ophelia syndrome with metabotropic glutamate receptor 5 antibodies in CSF.

Mat A, Adler H, Merwick A, Chadwick G, Gullo G, Dalmau JO, Tubridy N.

Neurology. 2013 Apr 2;80(14):1349-50. doi: 10.1212/WNL.0b013e31828ab325. Epub 2013 Mar 13. No abstract available.

36.

Symptom overlap in anxiety and multiple sclerosis.

Ó Donnchadha S, Burke T, Bramham J, O'Brien MC, Whelan R, Reilly R, Kiiski H, Lonergan R, Kinsella K, Kelly S, McGuigan C, Hutchinson M, Tubridy N.

Mult Scler. 2013 Sep;19(10):1349-54. doi: 10.1177/1352458513476742. Epub 2013 Feb 14.

PMID:
23413298
37.

Relating health-related Quality of Life to disability progression in multiple sclerosis, using the 5-level EQ-5D.

Fogarty E, Walsh C, Adams R, McGuigan C, Barry M, Tubridy N.

Mult Scler. 2013 Aug;19(9):1190-6. doi: 10.1177/1352458512474860. Epub 2013 Feb 11.

PMID:
23401128
38.

Parkinson's disease: how is employment affected?

Murphy R, Tubridy N, Kevelighan H, O'Riordan S.

Ir J Med Sci. 2013 Sep;182(3):415-9. doi: 10.1007/s11845-013-0902-5. Epub 2013 Jan 17.

PMID:
23325501
39.

A web-based electronic neurology referral system: a solution for an overburdened healthcare system?

Williams L, O'Riordan S, McGuigan C, Hutchinson M, Tubridy N.

Ir Med J. 2012 Oct;105(9):301-3.

PMID:
23240282
40.

A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.

Kelly SB, Kinsella K, Duggan M, Tubridy N, McGuigan C, Hutchinson M.

Mult Scler. 2013 Jul;19(8):1095-100. doi: 10.1177/1352458512464829. Epub 2012 Nov 6.

PMID:
23132903
41.

Only low frequency event-related EEG activity is compromised in multiple sclerosis: insights from an independent component clustering analysis.

Kiiski H, Reilly RB, Lonergan R, Kelly S, O'Brien MC, Kinsella K, Bramham J, Burke T, O Donnchadha S, Nolan H, Hutchinson M, Tubridy N, Whelan R.

PLoS One. 2012;7(9):e45536. doi: 10.1371/journal.pone.0045536. Epub 2012 Sep 21.

42.

Does natalizumab therapy worsen neuromyelitis optica?

Jacob A, Hutchinson M, Elsone L, Kelly S, Ali R, Saukans I, Tubridy N, Boggild M.

Neurology. 2012 Sep 4;79(10):1065-6. doi: 10.1212/WNL.0b013e31826845fe. Epub 2012 Aug 22. No abstract available.

PMID:
22914835
43.

Response to comment on the article by Allen et al. 'A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers'.

Fletcher J, Hutchinson M, Tubridy N.

Mult Scler. 2013 Apr;19(4):509. doi: 10.1177/1352458512457849. Epub 2012 Aug 20. No abstract available.

PMID:
22907945
44.

A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers.

Allen AC, Kelly S, Basdeo SA, Kinsella K, Mulready KJ, Mills KH, Tubridy N, Walsh C, Brady JJ, Hutchinson M, Fletcher JM.

Mult Scler. 2012 Dec;18(12):1797-800. doi: 10.1177/1352458512442992. Epub 2012 Mar 28.

PMID:
22457344
45.

Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.

Patsopoulos NA; Bayer Pharma MS Genetics Working Group; Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist; ANZgene Consortium; GeneMSA; International Multiple Sclerosis Genetics Consortium, Esposito F, Reischl J, Lehr S, Bauer D, Heubach J, Sandbrink R, Pohl C, Edan G, Kappos L, Miller D, Montalbán J, Polman CH, Freedman MS, Hartung HP, Arnason BG, Comi G, Cook S, Filippi M, Goodin DS, Jeffery D, O'Connor P, Ebers GC, Langdon D, Reder AT, Traboulsee A, Zipp F, Schimrigk S, Hillert J, Bahlo M, Booth DR, Broadley S, Brown MA, Browning BL, Browning SR, Butzkueven H, Carroll WM, Chapman C, Foote SJ, Griffiths L, Kermode AG, Kilpatrick TJ, Lechner-Scott J, Marriott M, Mason D, Moscato P, Heard RN, Pender MP, Perreau VM, Perera D, Rubio JP, Scott RJ, Slee M, Stankovich J, Stewart GJ, Taylor BV, Tubridy N, Willoughby E, Wiley J, Matthews P, Boneschi FM, Compston A, Haines J, Hauser SL, McCauley J, Ivinson A, Oksenberg JR, Pericak-Vance M, Sawcer SJ, De Jager PL, Hafler DA, de Bakker PI.

Ann Neurol. 2011 Dec;70(6):897-912. doi: 10.1002/ana.22609. Erratum in: Ann Neurol. 2013 Apr;73(4):561.

46.

Spontaneous intracranial hypotension: case reports and literature review.

O'Brien M, O'Keeffe D, Hutchinson M, Tubridy N.

Ir J Med Sci. 2012 Jun;181(2):171-7. doi: 10.1007/s11845-011-0766-5. Epub 2011 Oct 5. Review.

PMID:
21971699
47.

Failure to attend out-patient clinics: is it in our DNA?

Roberts K, Callanan I, Tubridy N.

Int J Health Care Qual Assur. 2011;24(5):406-12.

PMID:
21916092
48.

A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis.

Pallin M, O'Sullivan C, Dodd JD, McCreery K, Brett F, Farrell M, O'Brien D, Hall WW, Tubridy NJ, Keane MP.

QJM. 2012 Oct;105(10):1011-6. Epub 2011 Sep 5. No abstract available.

PMID:
21893584
49.

Using atypical symptoms and red flags to identify non-demyelinating disease.

Kelly SB, Chaila E, Kinsella K, Duggan M, Walsh C, Tubridy N, Hutchinson M.

J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):44-8. doi: 10.1136/jnnp-2011-300679. Epub 2011 Aug 17.

PMID:
21849338
50.

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B, Gwilliam R, Zipp F, Jayakumar A, Martin R, Leslie S, Hawkins S, Giannoulatou E, D'alfonso S, Blackburn H, Martinelli Boneschi F, Liddle J, Harbo HF, Perez ML, Spurkland A, Waller MJ, Mycko MP, Ricketts M, Comabella M, Hammond N, Kockum I, McCann OT, Ban M, Whittaker P, Kemppinen A, Weston P, Hawkins C, Widaa S, Zajicek J, Dronov S, Robertson N, Bumpstead SJ, Barcellos LF, Ravindrarajah R, Abraham R, Alfredsson L, Ardlie K, Aubin C, Baker A, Baker K, Baranzini SE, Bergamaschi L, Bergamaschi R, Bernstein A, Berthele A, Boggild M, Bradfield JP, Brassat D, Broadley SA, Buck D, Butzkueven H, Capra R, Carroll WM, Cavalla P, Celius EG, Cepok S, Chiavacci R, Clerget-Darpoux F, Clysters K, Comi G, Cossburn M, Cournu-Rebeix I, Cox MB, Cozen W, Cree BA, Cross AH, Cusi D, Daly MJ, Davis E, de Bakker PI, Debouverie M, D'hooghe MB, Dixon K, Dobosi R, Dubois B, Ellinghaus D, Elovaara I, Esposito F, Fontenille C, Foote S, Franke A, Galimberti D, Ghezzi A, Glessner J, Gomez R, Gout O, Graham C, Grant SF, Guerini FR, Hakonarson H, Hall P, Hamsten A, Hartung HP, Heard RN, Heath S, Hobart J, Hoshi M, Infante-Duarte C, Ingram G, Ingram W, Islam T, Jagodic M, Kabesch M, Kermode AG, Kilpatrick TJ, Kim C, Klopp N, Koivisto K, Larsson M, Lathrop M, Lechner-Scott JS, Leone MA, Leppä V, Liljedahl U, Bomfim IL, Lincoln RR, Link J, Liu J, Lorentzen AR, Lupoli S, Macciardi F, Mack T, Marriott M, Martinelli V, Mason D, McCauley JL, Mentch F, Mero IL, Mihalova T, Montalban X, Mottershead J, Myhr KM, Naldi P, Ollier W, Page A, Palotie A, Pelletier J, Piccio L, Pickersgill T, Piehl F, Pobywajlo S, Quach HL, Ramsay PP, Reunanen M, Reynolds R, Rioux JD, Rodegher M, Roesner S, Rubio JP, Rückert IM, Salvetti M, Salvi E, Santaniello A, Schaefer CA, Schreiber S, Schulze C, Scott RJ, Sellebjerg F, Selmaj KW, Sexton D, Shen L, Simms-Acuna B, Skidmore S, Sleiman PM, Smestad C, Sørensen PS, Søndergaard HB, Stankovich J, Strange RC, Sulonen AM, Sundqvist E, Syvänen AC, Taddeo F, Taylor B, Blackwell JM, Tienari P, Bramon E, Tourbah A, Brown MA, Tronczynska E, Casas JP, Tubridy N, Corvin A, Vickery J, Jankowski J, Villoslada P, Markus HS, Wang K, Mathew CG, Wason J, Palmer CN, Wichmann HE, Plomin R, Willoughby E, Rautanen A, Winkelmann J, Wittig M, Trembath RC, Yaouanq J, Viswanathan AC, Zhang H, Wood NW, Zuvich R, Deloukas P, Langford C, Duncanson A, Oksenberg JR, Pericak-Vance MA, Haines JL, Olsson T, Hillert J, Ivinson AJ, De Jager PL, Peltonen L, Stewart GJ, Hafler DA, Hauser SL, McVean G, Donnelly P, Compston A.

Nature. 2011 Aug 10;476(7359):214-9. doi: 10.1038/nature10251.

Supplemental Content

Loading ...
Support Center